共 8 条
[1]
Application of machine vision to assess involved surface in patients with psoriasis. Savolainen. L,Kontinen. J,Roning J,et al. Br J Dermatol . 1997
[2]
The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity: persisting areas of confusion. van de Kerkhof PC. Br J Dermatol . 1997
[3]
The psoriasis area and severity index and alternative approaches for the assessment of severity: persisting areas of confusion. Van De Kerkhof PCM. Br J Dermatol . 1997
[4]
Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS),and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the DeadSea. Harari M,Shani J,Hristakieva M,et al. International Journal of Dermatology . 2000
[5]
The self-administered PASI. Feldman SR,Fleischer AB,Reboussin DM,et al. Journal of Investigative Dermatology . 1996
[6]
Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI.The Cavide Research Group. Badia X,Mascaro JM,Lozano R. Br J Dermatol . 1999
[7]
Clinical measures of disease severity and outcome on psoriasis: a critical appraisal of their quality. Ashcroft DM,Wanpo L,Williams HC,et al. Br J Dermatol . 1999
[8]
Reliability testing of the Dermatology Index of Disease Severity (DIDS): an index for staging the severity of cutaneous inflammatory disease. Faust HB,Gonin R,Chuang TY,et al. Archives of Dermatology . 1997